CU6 Ann: IND approval from the FDA for theranostic SAR-Bombesin trial - 21st Nov 2022, 9:50am

[annb0t]

CU6 Ann: IND approval from the FDA for theranostic SAR-Bombesin trial
Price Sensitive: Y
Date: 21st Nov 2022, 9:50am

>>> Read announcement: Google: CU6 Market Announcements